OraSure Technologies (OSUR) : Traders are bullish on OraSure Technologies (OSUR) as it has outperformed the S&P 500 by a wide margin of 27.22% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.99%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.53% in the last 1 week, and is up 24.64% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 5.64% and the 50-Day Moving Average is 18.35%.The 200 Day SMA reached 26.32% OraSure Technologies, Inc. is up 24.64% in the last 3-month period. Year-to-Date the stock performance stands at 34.32%.
For this week, the average consensus of the company shares are rated as a Strong Buy. OraSure Technologies (NASDAQ:OSUR): stock was range-bound between the intraday low of $8.58 and the intraday high of $8.87 after having opened at $8.66 on Fridays session. The stock finally closed in the red at $8.66, a loss of -0.35%. The stock remained in the red for the whole trading day. The total traded volume was 1,082,112 shares. The stock failed to cross $8.87 in Fridays trading. The stocks closing price on Thursday was $8.65.
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.